Sciences and Regulatory Issues
Our science and regulatory affairs tracks will provide up-to-date insight and context to today’s developments and trends so you can better navigate the twists and turns of the regulatory landscape for generic and biosimilar drug applications. You will have the opportunity to hear from subject matter experts, as well as engage with them and other experts from FDA, industry, and academia, to better inform your business strategies and optimize your results.